yttrium Y 90 DOTA monoclonal antibody HuAFP31
Semantic Scholar uses AI to extract papers important to this topic.
Paired imaging/therapy with radiolabeled somatostatin receptor (SSTR) antagonists is a novel approach in neuroendocrine tumors… Expand Purpose: Radiolabeled somatostatin receptor 2 (SSTR2) antagonists have shown higher tumor uptake and tumor-to-organ ratios than… Expand Intra-arterial radionuclide therapies serve essentially as internal radiation treatment options for both primary and metastatic… Expand The commercial pipeline of recombinant antibody therapeutics is robust and dynamic. As of early December 2014, a total of 6 such… Expand The commercial pipeline of monoclonal antibodies is highly dynamic, with a multitude of transitions occurring during the year as… Expand The biodistribution of the anti-CD37 radioimmunoconjugate 177Lu-tetraxetan-tetulomab (177Lu-DOTA-HH1) was evaluated… Expand Objective: Hepatic artery perfusion scintigraphy is a routine procedure for patient evaluation before Y-90 radiomicrosphere… Expand Pancreatic cancer is a silent disease that most commonly presents in an already metastatic form. Current treatment options… Expand The use of selective internal radiation therapy for treatment of hepatocellular carcinoma and liver metastases using Y-90 labeled… Expand